← FDA DRUG APPROVALS
FDA ANDA · ANDA211475
VALGANCICLOVIR
valganciclovir hydrochloride
Sponsor: HETERO LABS LTD V
APPLICATION
ANDA211475
TYPE
ANDA
ORIGINAL APPROVAL
2022-10-04
LATEST ACTION
2022-10-04
ROUTE
ORAL
DOSAGE FORM
FOR SOLUTION
MARKETING STATUS
Prescription
Products
VALGANCICLOVIR HYDROCHLORIDEPrescription
VALGANCICLOVIR HYDROCHLORIDE 50MG/ML · FOR SOLUTION · ORAL
Approval history
2022-10-04UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.